13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001773206
Total reported value
$2.5B
$2.5B
86 檔
32.2%
According to the latest 13F quarterly dataset, Integral Health Asset Management, LLC managed an equity portfolio of $2.5B at the end of Q1 2026, spanning 86 distinct U.S. exchange-listed positions.
Integral Health Asset Management, LLC executed strategic sector rebalancing during Q1 2026, establishing 28 new positions while fully exiting 26 holdings and trimming 17 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 12.79% | +0.53% | +129.17% | |
| 2 | INSM | Insmed Inc | Stock-Healthcare | 11.73% | -4.99% | +20.00% | |
| 3 | CYTK | Cytokinetics Inc | Stock-Healthcare | 8.20% | -2.82% | +36.84% | |
| 4 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 3.14% | -2.15% | -19.05% | |
| 5 | VERA | Vera Therapeutics Inc | Stock-Other | 3.08% | -0.11% | -11.11% | |
| 6 | CAH | Cardinal Health Inc | Stock-Healthcare | 2.73% | +0.09% | +35.00% | |
| 7 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 2.65% | +0.15% | +135.29% | |
| 8 | BTSG | Brightspring Health Services | Stock-Other | 2.55% | -1.03% | +66.67% | |
| 9 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 2.50% | -0.09% | +26.32% | |
| 10 | MRK | Merck & Co. Inc. | Stock-Healthcare | 2.45% | -0.66% | +70.00% | |
| 11 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 2.41% | +0.80% | +6.67% | |
| 12 | AZN | AstraZeneca PLC | Stock-Healthcare | 2.36% | -2.36% | EXIT | |
| 13 | ALHC | Alignment Healthcare Inc | Stock-Other | 2.17% | -0.29% | +17.05% | |
| 14 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 1.83% | -0.59% | — | |
| 15 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.65% | -0.13% | +144.44% | |
| 16 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 1.62% | -1.14% | +25.00% | |
| 17 | LFST | Lifestance Health Group Inc | Stock-Other | 1.31% | -0.04% | +43.33% | |
| 18 | ASND | Ascendis Pharma A/S | Stock-Other | 1.26% | -1.26% | EXIT | |
| 19 | SRRK | Scholar Rock Holding CORP | Stock-Other | 1.18% | +0.45% | +66.67% | |
| 20 | ELV | Elevance Health Inc | Stock-Healthcare | 1.05% | -0.29% | +25.00% | |
| 21 | CNC | Centene CORP | Stock-Healthcare | 1.02% | -0.26% | — | |
| 22 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 0.98% | -0.17% | — | |
| 23 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 0.95% | +0.05% | — | |
| 24 | GKOS | Glaukos CORP | Stock-Healthcare | 0.90% | -0.07% | -46.15% | |
| 25 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 0.90% | -0.26% | +200.00% | |
| 26 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.85% | -0.07% | — | |
| 27 | ORIC | Oric Pharmaceuticals Inc | Stock-Other | 0.85% | -0.04% | +16.67% | |
| 28 | ALMS | Alumis Inc | Stock-Other | 0.84% | -0.06% | — | |
| 29 | FMS | Fresenius Medical Care-adr | Stock-Other | 0.84% | -0.84% | EXIT | |
| 30 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.77% | -0.77% | EXIT | |
| 31 | QURE | uniQure N.V. | Stock-Other | 0.70% | +0.94% | — | |
| 32 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 0.67% | -0.67% | EXIT | |
| 33 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.67% | -0.67% | EXIT | |
| 34 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.66% | +0.05% | -25.00% | |
| 35 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.65% | +1.58% | -47.69% | |
| 36 | COGT | Cogent Biosciences Inc | Stock-Other | 0.64% | -0.33% | — | |
| 37 | ELAN | Elanco Animal Health Inc | Stock-Healthcare | 0.63% | -0.63% | EXIT | |
| 38 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.63% | -0.10% | — | |
| 39 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.62% | -0.09% | — | |
| 40 | DNTH | Dianthus Therapeutics Inc | Stock-Other | 0.60% | -0.60% | EXIT | |
| 41 | RGNX | Regenxbio Inc | Stock-Other | 0.60% | -0.22% | +25.00% | |
| 42 | DGX | Quest Diagnostics Inc | Stock-Healthcare | 0.56% | +1.11% | -20.00% | |
| 43 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.56% | -0.08% | — | |
| 44 | ERAS | Erasca Inc | Stock-Other | 0.54% | +0.18% | — | |
| 45 | ANRO | Alto Neuroscience Inc | Stock-Other | 0.54% | -0.02% | +33.33% | |
| 46 | BIIB | Biogen Inc | Stock-Healthcare | 0.53% | +0.32% | -40.00% | |
| 47 | DXCM | Dexcom Inc | Stock-Healthcare | 0.53% | -0.53% | EXIT | |
| 48 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 0.52% | -0.52% | EXIT | |
| 49 | IRON | Disc Medicine Inc | Stock-Other | 0.52% | -0.52% | EXIT | |
| 50 | NRIX | Nurix Therapeutics Inc | Stock-Other | 0.52% | -0.52% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | +8% | +129.17% | Add |
| 2 | CYTK | Cytokinetics Inc | +2.2% | +36.84% | Add |
| 3 | ROIV | Roivant Sciences Ltd. | +1.7% | +135.29% | Add |
| 4 | BTSG | Brightspring Health Services | +1.2% | +66.67% | Add |
| 5 | MRK | Merck & Co. Inc. | +1.1% | +70.00% | Add |
| 6 | INSM | Insmed Inc | +0.9% | +20.00% | Add |
| 7 | CAH | Cardinal Health Inc | +0.7% | +35.00% | Add |
| 8 | BSX | Boston Scientific CORP | +0.6% | +144.44% | Add |
| 9 | ARWR | Arrowhead Pharmaceuticals In | +0.6% | +200.00% | Add |
| 10 | EWTX | Edgewise Therapeutics Inc | +0.6% | +6.67% | Add |
| 11 | SRRK | Scholar Rock Holding CORP | +0.5% | +66.67% | Add |
| 12 | ORIC | Oric Pharmaceuticals Inc | +0.4% | +16.67% | Add |
| 13 | TNGX | Tango Therapeutics Inc | +0.4% | +125.00% | Add |
| 14 | ELAN | Elanco Animal Health Inc | +0.4% | +120.00% | Add |
| 15 | ASND | Ascendis Pharma A/S | +0.3% | +27.78% | Add |
| 16 | LFST | Lifestance Health Group Inc | +0.3% | +43.33% | Add |
| 17 | NRIX | Nurix Therapeutics Inc | +0.2% | +133.33% | Add |
| 18 | VKTX | Viking Therapeutics Inc | +0.2% | +150.00% | Add |
| 19 | ANRO | Alto Neuroscience Inc | +0.2% | +33.33% | Add |
| 20 | SNDX | Syndax Pharmaceuticals Inc | +0.2% | +75.00% | Add |
| 21 | EVMN | Evommune Inc | +0.1% | +80.00% | Add |
| 22 | NVS | Novartis Ag-sponsored Adr | +0.1% | — | Unchanged |
| 23 | LNTH | Lantheus Holdings Inc | +0.1% | +25.00% | Add |
| 24 | FMS | Fresenius Medical Care-adr | +0.1% | +19.23% | Add |
| 25 | LBRX | Lb Pharmaceuticals Inc | +0.1% | +50.00% | Add |
| 26 | RZLT | Rezolute Inc | +0.1% | — | Unchanged |
| 27 | DNTH | Dianthus Therapeutics Inc | 0% | -45.45% | Trim |
| 28 | CELC | Celcuity Inc | 0% | — | Unchanged |
| 29 | PRAX | Praxis Precision Medicines I | 0% | — | Unchanged |
| 30 | TENX | Tenax Therapeutics Inc | 0% | — | Unchanged |
| 31 | ALHC | Alignment Healthcare Inc | 0% | +17.05% | Add |
| 32 | ELV | Elevance Health Inc | 0% | +25.00% | Add |
| 33 | RYTM | Rhythm Pharmaceuticals Inc | 0% | +26.32% | Add |
| 34 | IKT | Inhibikase Therapeutics Inc | -0.1% | -22.86% | Trim |
| 35 | MAZE | Maze Therapeutics Inc | -0.1% | — | Unchanged |
| 36 | DGX | Quest Diagnostics Inc | -0.1% | -20.00% | Trim |
| 37 | NBIX | Neurocrine Biosciences Inc | -0.1% | — | Unchanged |
| 38 | NVST | Envista Holdings CORP | -0.1% | -30.00% | Trim |
| 39 | TARS | Tarsus Pharmaceuticals Inc | -0.1% | — | Unchanged |
| 40 | TARA | Protara Therapeutic Inc | -0.2% | -22.22% | Trim |
| 41 | SANA | Sana Biotechnology Inc | -0.2% | +6.67% | Add |
| 42 | MLYS | Mineralys Therapeutics Inc | -0.2% | +25.00% | Add |
| 43 | SLNOEUR | Soleno Therapeutics Inc | -0.2% | — | Unchanged |
| 44 | RGNX | Regenxbio Inc | -0.3% | +25.00% | Add |
| 45 | CNC | Centene CORP | -0.3% | — | Unchanged |
| 46 | BIIB | Biogen Inc | -0.3% | -40.00% | Trim |
| 47 | QURE | uniQure N.V. | -0.4% | — | Unchanged |
| 48 | LLY | Eli Lilly & Co | -0.4% | -25.00% | Trim |
| 49 | BEAM | Beam Therapeutics Inc | -0.4% | -45.45% | Trim |
| 50 | BHVN | Biohaven Ltd. | -0.4% | -33.33% | Trim |
According to official SEC Form 13F filings, Integral Health Asset Management, LLC reported a total U.S. public equity portfolio value of $2.5B across 86 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including RVMD, INSM, CYTK) accounted for 32.2% of total reported equity market value during Q1 2026.
Top New Position Initiated
AZN
市值: $49.3M
Top Position Liquidated / Trimmed
MDT
前期市值: $64.8M
During Q1 2026, Integral Health Asset Management, LLC's top holdings by market value included RVMD (12.8%)、INSM (11.7%)、CYTK (8.2%). The largest single position, RVMD, represented 12.8% of total portfolio value.
In Q1 2026, Integral Health Asset Management, LLC made 101 total portfolio adjustments, initiating 28 new buys, adding to 30 positions, trimming 17 holdings, and fully liquidating 26 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.